Bill Gates Coughs Up $26.5 Million To Keep Cow's Farts At Bay

By Jennifer Wentworth | Monday, 13 May 2024 04:30 PM
Views 2.7K
Image Credit : Photo by The New York Times

Boston-based vaccine developer ArkeaBio has received a significant investment of $26.5 million, led by Breakthrough Energy Ventures, a fund established by renowned billionaire Bill Gates.

The funding is aimed at supporting the company's innovative approach to mitigating climate change by reducing methane emissions from livestock through vaccination.

According to climate activists, livestock's methane emissions, primarily through belching and flatulence, contribute to over 5% of global greenhouse gas emissions, as reported by Axios. Methane is a potent greenhouse gas, with a heat-trapping capacity significantly higher than that of carbon dioxide, scientists assert.

Breakthrough Energy Ventures initiated the funding round with a $12 million investment, as per the outlet. Other investors include the Grantham Foundation, AgriZeroNZ, Rabo Ventures, Overview Capital, and The51 Food & AgTech Fund.

The Bill and Melinda Gates Foundation, known for its extensive funding in vaccine research and distribution, has a stated mission "to advance public goods for global health through technological innovation by accelerating the development and commercialization of novel vaccines and the sustainable manufacture of existing vaccines, defining the global disease burden through better primary data and world-class modeling, and reducing the threat of epidemics through the development and use of innovative tools."


The foundation's portfolio includes funding for vaccines against diseases such as Covid-19, HPV, polio, and HIV, among others. This latest investment in ArkeaBio aligns with the foundation's commitment to leveraging technological innovation for global health and environmental sustainability.